MedTrace Logo

Cognitive Hyper-performance - Effects of Stimulating Substances in Chess-players

NCT01834547 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2013-04-18

No results posted yet for this study

Summary

Effects of caffeine, methylphenidate, modafinil and placebo on cognitive performance of chess players in chess games and neuropsychiatric standardized tests. We hypothesize that substances will change cognitive performance in chess players leading to changed results in chess games and neuropsychiatric tests.

Conditions

  • Cognitively Healthy Subjects Influenced by Psychoactive Drugs

Interventions

DRUG

Drugs use: methylphenidate

40 mg tablets

DRUG

Drug use: modafinil

40 mg tablets

DRUG

caffeine

400 mg

DRUG

placebo

placebo

Sponsors & Collaborators

  • K. Lieb

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
TRIPLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
60 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2011-05-31
Primary Completion
2013-04-30
Completion
2013-04-30

Countries

  • Germany

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01834547 on ClinicalTrials.gov